课题基金 / 基金详情

A study of growth mechanism of leukemic blast progenitors in AML.

A study of growth mechanism of leukemic blast progenitors in AML.
AML中白血病原始细胞生长机制的研究。
批准号:
04671535
负责人:
MUROHASHI Ikuo
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

MUROHASHI Ikuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The growth of leukemic blast progenitors from AML patients is under the control of complex network of cytokines. Among cytokines produced by AML blasts and stimulate the growth of their own progenitors, TNF-a possess most powerful effect. We investigated the effects of various cytokines on the growth of leukemic blast progenitors and expression of proto-oncogenes, induction of apoptosis, and cell cycle of blasts.1. Role of TGF-b1. TGF-b1 did not affect the growth of G-CSF supported normal hematopoietic progenitors, but suppressed the one supported by GM-CSF, IL-3, or SCF, and the suppression by TGF-b1 was increased in this order. TGF-b1 profoundly suppressed the growth of leukemic blast progenitors, irrespective of growth factor used. By experiments with c-Myc and c-Myb antisense oligonucleotides and Northern blot analysis, c-Myc and c-Myb may be directly related to TGF-b1 suppression. In normal hematopoietic progenitors, TGF-b1 preferentially suppressed the primitive ones. In hematolo … More gic malignancies, TGF-b1 suppression was increased with progression of clonal evolution, and may be related to the activation of endogenous tyrosine kinase activity. TGF-b1 inhibited the expression of c-kit and Fas mRNA by AML blasts, and seems to act against apoptosis and differentiation.2. Role of TNF-a. TNF-a alone enhanced the transition of AML blasts to S phase, but failed to stimulate the growth of leukemic blast progenitors. In the presence of cytokine such as IL-3, TNF-a powerfully stimulated the clonogenic cell growth. TNF-a stimulated the expression of c-kit, c-jun, and Fas mRNA by blasts, and induced differentiation of the cells. TGF-b1 almost completely abolished growth stimulating effect of TNF-a.Induction of apoptosis of AML blasts. When AMl blasts were cultured in vitro in the absence of growth factor, expression of c-jun and c-fos mRNA, transition into S phase, and induction of apoptosis of the cells were observed. Addition of factor such as IL-3 prevented apoptosis and suppressed c-jun transcript and enhanced c-fos transcript. In some AML cases, cells remained in G0/G1 phase, and did not express c-jun and c-fos mRNA, and apoptosis was not observed. The proportion of c-Jun/c-Fos may play an importent role in induction of apoptosis of AML blasts. Less
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
I.Murohashi et al: "Growth potentiating activity of endogenous production of interleukin-1 and tumor necrosis factor in blast cells of.." Exp Hematol. 21. 846-851 (1993)
I.Murohashi 等人:“母细胞中白细胞介素 1 和肿瘤坏死因子内源性产生的生长增强活性。”Exp Hematol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Jinnai: "A clonal study of hematopoiesis using M27 probe : aberrant band patters caused by incomplete digestion of a methyl-sensitive enzyme in the inactive X-chromosome." Leukemia. 7. 1432-1436 (1993)
Jinnai:“使用 M27 探针进行造血克隆研究:由于非活性 X 染色体中甲基敏感酶的不完全消化而导致异常条带模式。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N. Nara et al: "The in vitro growth patterns and drug sensitvities of leukemic blast progenitors among the subtypes of acutemyeloblastic leuekmia." Experimental Hematology. 20. 904-908 (1992)
N. Nara 等人:“急性髓细胞性白血病亚型中白血病细胞祖细胞的体外生长模式和药物敏感性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
室橋 郁生 他: "「造血幹細胞増殖分化の機構の学際的研究」於三島 TNF-αによる白血病幹細胞増殖調節機構" 最新医学. 43(1993年、2月号、別刷). 156-157 (1993)
Ikuo Murohashi 等:“造血干细胞增殖和分化机制的跨学科研究”,《Mishima TNF-α 介导的白血病干细胞增殖调节机制》43(1993 年 2 月,重印)。 1993))
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Constitutuve activation of MAPK activity in leukemic cells-its role in cellular proliferration
    国内基金
    海外基金
    基于多组学与可视化免疫动态成像技术解析EZH2抑制对增强CAR-NK细胞抗AML效应的机制研究
    • 批准号:
      JCZRLH202600775
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于CD99靶点CAR-T产品治疗T-ALL/AML的安全性与有效性研究
    • 批准号:
      JCZRLH202600888
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    肌动蛋白网络调控AML化疗敏感性与免疫逃逸的机制研究及预后预测模型构建
    • 批准号:
      JCZRLH202601101
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    DADS调控自噬流转换决定AML细胞命运的机制研究